BAMBI Elimination Enhances Alternative TGF-β Signaling and Glomerular Dysfunction in Diabetic Mice
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
BMP, activin, membrane-bound inhibitor (BAMBI) acts as a pseudo-receptor for the transforming growth factor (TGF)-β type I receptor family and a negative modulator of TGF-β kinase signaling, and BAMBI−/− mice show mild endothelial dysfunction. Because diabetic glomerular disease is associated with TGF-β overexpression and microvascular alterations, we examined the effect of diabetes on glomerular BAMBI mRNA levels. In isolated glomeruli from biopsies of patients with diabetic nephropathy and in glomeruli from mice with type 2 diabetes, BAMBI was downregulated. We then examined the effects of BAMBI deletion on streptozotocin-induced diabetic glomerulopathy in mice. BAMBI−/− mice developed more albuminuria, with a widening of foot processes, than BAMBI+/+ mice, along with increased activation of alternative TGF-β pathways such as extracellular signal–related kinase (ERK)1/2 and Smad1/5 in glomeruli and cortices of BAMBI−/− mice. Vegfr2 and Angpt1, genes controlling glomerular endothelial stability, were downmodulated in glomeruli from BAMBI−/− mice with diabetes. Incubation of glomeruli from nondiabetic BAMBI+/+ or BAMBI−/− mice with TGF-β resulted in the downregulation of Vegfr2 and Angpt1, effects that were more pronounced in BAMBI−/− mice and were prevented by a MEK inhibitor. The downregulation of Vegfr2 in diabetes was localized to glomerular endothelial cells using a histone yellow reporter under the Vegfr2 promoter. Thus, BAMBI modulates the effects of diabetes on glomerular permselectivity in association with altered ERK1/2 and Smad1/5 signaling. Future therapeutic interventions with inhibitors of alternative TGF-β signaling may therefore be of interest in diabetic nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“but canonical TGFβ signalling, as assessed by phosphorylation of Mothers against decapentaplegic homologue 3 (SMAD3) and expression of its target genes in glomeruli, was comparable in diabetic Bambi-knockout mice and diabetic wild-type mice.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [159]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“BAMBI was downregulated in glomeruli isolated from biopsy samples of patients with DKD compared with samples from healthy donors, and in the glomeruli of STZ-induced diabetic mice compared with wild-type controls159.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [159]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“which suggests that Bambi deletion enhances alternative TGFβ signalling in DKD159.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [159]
The cited source says what the claim attributes to it.
In the citing paper
“STZ-induced diabetic mice with Bambi deletion displayed more severe glomerulopathy than diabetic wild-type mice159.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [159]
The cited source says what the claim attributes to it.
In the citing paper
“However, mitogen-activated protein kinase 3/1 (also known as ERK1/2) signalling and SMAD1/5 signalling in glomeruli were enhanced in diabetic Bambi-knockout mice compared with diabetic wild-type mice”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [159]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
VEGF Inhibition and Renal Thrombotic Microangiopathy
Eremina, V., Jefferson, J. A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., Richardson, C., Kopp, J. B., Kabir, M. G., Backx, P. H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707330 · Cited by 1,504
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Oh, S. P., Seki, T., Goss, K. A., Imamura, T., Yi, Y., Donahoe, P. K., Li, L., Miyazono, K., ten Dijke, P., Kim, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.6.2626 · Cited by 851
Endothelial dysfunction — A major mediator of diabetic vascular disease
Sena, C. M., Pereira, A. M., & Seiça, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.006 · Cited by 797
Silencing of TGF-β signalling by the pseudoreceptor BAMBI
Onichtchouk, D., Chen, Y.-G., Dosch, R., Gawantka, V., Delius, H., Massague´, J., & Niehrs, C. (1999) · Nature · doi:10.1038/46794 · Cited by 726
Sharma, K., Jin, Y., Guo, J., & Ziyadeh, F. N. (1996) · Diabetes · doi:10.2337/diab.45.4.522 · Cited by 662
Transcriptome Analysis of Human Diabetic Kidney Disease
Woroniecka, K. I., Park, A. S. D., Mohtat, D., Thomas, D. B., Pullman, J. M., & Susztak, K. (2011) · Diabetes · doi:10.2337/db10-1181 · Cited by 642
Cited by
Autophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease
Murphy-Ullrich, J. E., & Suto, M. J. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.12.009 · Cited by 332
Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential
Yang, D., Livingston, M. J., Liu, Z., Dong, G., Zhang, M., Chen, J.-K., & Dong, Z. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2639-1 · Cited by 252
“The renoprotective role of BAMBI against glomerular injury in DKD was further confirmed using BAMBI-deficient mice [188].”
TGF-β family co-receptor function and signaling
Nickel, J., Ten Dijke, P., & Mueller, T. D. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx126 · Cited by 198
“Similarly, another study also identified only a mild endothelial dysfunction in BAMBI mice, although this mutation in diabetic mice resulted in glomerular abnormalities, thereby impairing kidney function [232].”
Transforming growth factor-β1 and diabetic nephropathy
Chang, A. S., Hathaway, C. K., Smithies, O., & Kakoki, M. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00502.2015 · Cited by 190
Zhu, K., Hu, X., Chen, H., Li, F., Yin, N., Liu, A.-L., Shan, K., Qin, Y.-W., Huang, X., Chang, Q., et al. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.10.004 · Cited by 169
LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β–Induced Angiogenesis
Hong, Q., Zhang, L., Fu, J., Verghese, D. A., Chauhan, K., Nadkarni, G. N., Li, Z., Ju, W., Kretzler, M., Cai, G., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018060599 · Cited by 164
Self-citationEbefors, K., Wiener, R. J., Yu, L., Azeloglu, E. U., Yi, Z., Fu, J., Zhang, W., Baron, M. H., He, C., Haraldsson, B. S., et al. (2019) · Kidney International · doi:10.1016/j.kint.2019.05.007 · Cited by 115
Self-citationRegulating Autophagy as a Therapeutic Target for Diabetic Nephropathy
Kitada, M., Ogura, Y., Monno, I., & Koya, D. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0879-y · Cited by 108
Reduction in podocyte SIRT1 accelerates kidney injury in aging mice
Chuang, P. Y., Cai, W., Li, X., Fang, L., Xu, J., Yacoub, R., He, J. C., & Lee, K. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00255.2017 · Cited by 98
Self-citationHong, Q., Cai, H., Zhang, L., Li, Z., Zhong, F., Ni, Z., Cai, G., Chen, X., He, C., & Lee, K. (2021) · Kidney International · doi:10.1016/j.kint.2021.10.023 · Cited by 107
Self-citationKnockdown of NLRP3 alleviates high glucose or TGFB1-induced EMT in human renal tubular cells
Song, S., Qiu, D., Luo, F., Wei, J., Wu, M. T., Wu, H., Du, C., Du, Y., Ren, Y., Chen, N., et al. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0069 · Cited by 95
Fu, J., Wei, C., Zhang, W., Schlöndorff, D., Wu, J., Cai, M., Wu, H., Baron, M. H., Chuang, P. Y., Liu, Z., et al. (2018) · Kidney International · doi:10.1016/j.kint.2018.02.028 · Cited by 92
Self-citationRole of VEGF-A and LRG1 in Abnormal Angiogenesis Associated With Diabetic Nephropathy
Zhang, A., Fang, H., Chen, J., He, L., & Chen, Y. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.01064 · Cited by 96
Endothelial Toxicity of High Glucose and its by-Products in Diabetic Kidney Disease
Dou, L., & Jourde‐Chiche, N. (2019) · Toxins · doi:10.3390/toxins11100578 · Cited by 79
“This occurs via the activation of the TGF-β alternative signaling pathway [36], and leads to a reduced responsiveness of GECs to VEGF [34].”
BackgroundTang, F., Hao, Y., Zhang, X., & Qin, J. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s143805 · Cited by 70
“In this study, type 2 diabetic mice were used as the research model to explore the protective effect of ECH on kidneys in DN and to explore possible mechanisms of action of ECH, so providing a theoretical basis for the treatment of DN.”
InfluentialTGF ‐β superfamily co‐receptors in cancer
Pawlak, J. B., & Blobe, G. C. (2021) · Developmental Dynamics · doi:10.1002/dvdy.338 · Cited by 75
Rtn1a-Mediated Endoplasmic Reticulum Stress in Podocyte Injury and Diabetic Nephropathy
Fan, Y., Zhang, J., Xiao, W., Lee, K., Li, Z., Wen, J., He, L. N., Gui, D., Xue, R., Jian, G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00305-6 · Cited by 59
Self-citationCircRNA–miRNA interactions in atherogenesis
Tong, K.-L., Tan, K., Lim, Y., Tien, X.-Y., & Wong, P. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04455-8 · Cited by 63
Protective effect of berberine on renal fibrosis caused by diabetic nephropathy
Zhong, L., & Zhang, W. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6707 · Cited by 58
“Transforming growth factor‑ β (TGF-β ) has been identified to be a key regulator of fibrosis in DN (5).”
Wang, X., Li, M., Hu, M., Wei, P., & Zhu, W. (2017) · Oncology Reports · doi:10.3892/or.2017.5508 · Cited by 45
“In vivo experiment showed that BAMBI transduction abolished protumor effects of an orthotopic breast cancer xenograft model (43) and modulated the effects of diabetes via inhibiting TGF-β signaling (44).”
BackgroundHernandez, H., Millar, J. C., Curry, S., Clark, A. F., & McDowell, C. M. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-23282 · Cited by 42
Yamamoto, C. M., Murakami, T., Oakes, M., Mitsuhashi, M., Kelly, C., Henry, R. R., & Sharma, K. (2018) · American Journal of Nephrology · doi:10.1159/000489129 · Cited by 49
Circulating Plasma Biomarkers in Biopsy-Confirmed Kidney Disease
Schmidt, I. M., Mothi, S. S., Wilson, P. C., Palsson, R., Srivastava, A., Onul, I. F., Kibbelaar, Z. A., Zhuo, M., Amodu, A., Stillman, I. E., et al. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09380721 · Cited by 37
Dendropanax morbifera Protects against Renal Fibrosis in Streptozotocin-Induced Diabetic Rats
Sachan, R., Kundu, A. B., Dey, P. K., Son, J. Y., Kim, K. S., Lee, D., Kim, H.-R., Park, J. H., Lee, S. H., Kim, J.-H., et al. (2020) · Antioxidants · doi:10.3390/antiox9010084 · Cited by 30
“Moreover, transforming growth factor-β (TGF-β), a well-known crucial regulator, contributes to the formation of kidney cell fibrosis in diabetic nephropathy [16].”
BackgroundZhao, P., Li, X., Li, Y., Zhu, J., Sun, Y., & Hong, J. (2021) · International Urology and Nephrology · doi:10.1007/s11255-021-02853-3 · Cited by 28
“Diabetes mellitus is a prevalent metabolic disorder leading to various chronic complications including peripheral neuropathy and retinopathy [1].”
BackgroundSelf-citationLai, H., Chen, A., Cai, H., Fu, J., Salem, F. E., Yu, L., He, C., Schlöndorff, D., & Lee, K. (2020) · Kidney International · doi:10.1016/j.kint.2020.03.036 · Cited by 30
Self-citationQiu, X., Lan, X., Li, L., Chen, H., ZHANG, N., Zheng, X., & Xie, X. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122866 · Cited by 27
Liang, D., Song, Z., Liang, W., Yan, L., & Liu, S. (2018) · Nephrology · doi:10.1111/nep.13430 · Cited by 23
“Decreased expression of BAMBI was found in isolated glomeruli from biopsies of patients with diabetic nephropathy and in glomeruli from mice with type 2 diabetes.(28) Until now, it has not been reported whether or not BAMBI is expressed in renal tubules.”
BackgroundTargeting the CDA1/CDA1BP1 Axis Retards Renal Fibrosis in Experimental Diabetic Nephropathy
Chai, Z., Wu, T., Dai, A., Huynh, P., Köentgen, F., Krippner, G. Y., Ren, S., & Cooper, M. E. (2018) · Diabetes · doi:10.2337/db18-0712 · Cited by 22
Chang, K., Xie, Q., Niu, J., Gu, Y., Zhao, Z., Li, F., Qin, Q., & Liu, X. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00858-0 · Cited by 19
“Activation of ERK1/2 was also observed in cultured GEnCs treated by high glucose [17, 22] as well as in the lysates of isolated glomeruli and cortices obtained from STZ-induced diabetic mice [37].”
BAMBI inhibits inflammation through the activation of autophagy in experimental spinal cord injury
Yang, Y., Guo, C., Liao, B., Cao, J., Chen, L., & He, X. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2838 · Cited by 21
“BAMBI elimination enhances alternative TGF-β signaling in diabetic mice (10), whereas it has been reported that the expression of TGF-β is markedly increased followng SCI (11).”
RetractedKuo, T., Hsu, H., Chung, C., Yeh, K., Wu, C.-T., Lee, C., Chiang, S., Huang, C., & Ko, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.010 · Cited by 18
Zhang, B., Chen, X., Xie, C., Chen, Z., Liu, Y., Ru, F., & He, Y. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111754 · Cited by 19
Fibrin fragment E potentiates TGF-β-induced myofibroblast activation and recruitment
Fuchs, P. Ö., Calitz, C., Pavlović, N., Binet, F., Solbak, S. M. Ø., Danielson, U. H., Kreuger, J., Heindryckx, F., & Gerwins, P. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109661 · Cited by 17
LRG1 loss effectively restrains glomerular TGF-β signaling to attenuate diabetic kidney disease
Wang, X., Sun, Z., Fu, J., Fang, Z., Zhang, W., He, C., & Lee, K. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.06.027 · Cited by 24
Self-citationLu, H.-J., Yan, J., Jin, P., Zheng, G., Zhang, H., Bai, M., Wu, D., Lu, J. L., & Zheng, Y. (2018) · Technology in Cancer Research & Treatment · doi:10.1177/1533034618756784 · Cited by 14
RetractedZhang, H., Wei, X., Lu, S., Lin, X., Huang, J., Chen, L., Huang, X., Jiang, L., Li, Y., Qin, L., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108705 · Cited by 13
RetractedFu, J., Yi, Z., Cai, M., Yuan, W., Zhang, W., Lee, K., & He, C. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03951-x · Cited by 13
Self-citationHsu, Y., Shih, Y., Ho, C., Liu, C.-C., Liaw, C., Lin, H.-Y., & Lin, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168986 · Cited by 12
“TGF-β 1 signaling is a well-established key mediator that promotes ECM accumulation in the mesangium and drives myofibroblast activation during the development of renal fibrosis in the diabetic milieu [6,47,48].”
Yi, J., Fan, Y., Zhang, L., Wang, H., Mu, T., Xie, H. Y., Gao, H., Liu, M., Li, S., & Tang, H. (2019) · Journal of Cancer · doi:10.7150/jca.30858 · Cited by 12
Self-citationMultiple novel functions of circular RNAs in diabetes mellitus
Tehrani, S. S., Goodarzi, G., Panahi, G., Maniati, M., & Meshkani, R. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1933047 · Cited by 12
Increased Levels of BAMBI Inhibit Canonical TGF-β Signaling in Chronic Wound Tissues
Ehnert, S., Rinderknecht, H., Liu, C., Voss, M., Konrad, F. M., Eisler, W., Alexander, D., Ngamsri, K., Histing, T., Rollmann, M. F. R., et al. (2023) · Cells · doi:10.3390/cells12162095 · Cited by 11
“Observations in BAMBI-/- mice suggest that BAMBI might inhibit not only the Smad-dependent canonical TGF-β signaling but also the Smad-independent non-canonical TGF-β signaling [15].”
BackgroundEZH2 serves as a promising therapeutic target for fibrosis
Zhang, Q., Wu, Y., Yu, X., Zhang, B., & Ma, L. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106578 · Cited by 11
Zheng, X., & Bhalla, V. (2015) · Diabetes · doi:10.2337/db15-0184 · Cited by 8
“(5) demonstrated that glomerular VEGFR2 is expressed only in endothelial cells, and activation of the TGF-b alternative signaling pathway decreases endothelial expression of VEGFR2.”
BackgroundInfluentialCrawley, J. T. B., Zalli, A., Monkman, J. H., Petri, A., Lane, D. A., Ahnström, J., & Salles‐Crawley, I. I. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14593 · Cited by 6
miR-19a-3p enhances TGF-β1-induced cardiac fibroblast activation via targeting BAMBI
Shi, P., Tan, A., Ma, Y., Que, L., Li, C., Shao, Y., Sun, H., Li, Y., & Li, J. (2024) · Journal of Biomedical Research · doi:10.7555/jbr.37.20230313 · Cited by 4
Arias, I., Jara, C., Mendoza, P., Nahuelpán, Y., Cappelli, C., Oyarzun, C. E., Carrillo-Beltrán, D., Quezada-Monrás, C., Torres, Á., & Martín, R. S. (2025) · Cells · doi:10.3390/cells14120890 · Cited by 4
Alk1 haploinsufficiency causes glomerular dysfunction and microalbuminuria in diabetic mice
Gil, C. L., Henley, N., Leblond, F. A., Akla, N., Laurin, L., Royal, V., Gerarduzzi, C., Pichette, V., & Larrivée, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-68515-z · Cited by 4
Xie, S., Ge, F., Yao, Y., Zhang, W., Wang, S., Zhang, M., Zhong, R., Fang, L., & Qu, D. (2019) · PubMed Central · Cited by 3
Braun, N. R., Nussler, A. K., & Ehnert, S. (2025) · Journal of Functional Biomaterials · doi:10.3390/jfb16100385 · Cited by 2
“While reduced TGF-β signaling is associated with impaired bone and wound healing [36–39] its prolonged or enhanced signaling is associated with fibrotic conditions, keloids, hypertrophic scar formation, and chronic wounds [19,35,40].”
Ramadan, A. (2022) · Sohag Medical Journal · doi:10.21608/smj.2022.131430.1315 · Cited by 2
“TGF signaling is important for the accumulation of ECM in DN (128) .”
BackgroundNangaku, M. (2020) · Kidney International · doi:10.1016/j.kint.2020.04.027 · Cited by 1
Corcelli, M., Sagar, R. L., Petzendorfer, E., Hasan, M. M., de Vries, H. I., van Dijk, F. S., David, A. L., & Guillot, P. V. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.15.580510
“…factor beta binding protein 4), which regulates the bioavailability of TGF-β 45 , as well as BAMBI (BMP and activin membrane-bound inhibitor), which inhibits signals from the TGF-β superfamily, including bone morphogenetic proteins (BMPs) and activins 46 , were less expressed in OIM osteoblasts.”
BackgroundYang, Z., Yang, Y., Guo, H., Gong, W., Qiu, J., Yan, Q., Chen, H., Li, H., Zeng, Z., Liu, F., et al. (2025) · Gene · doi:10.1016/j.gene.2025.149648 · Cited by 1
Cunningham, K. T., Ciancia, C., Campion, T., van Dinther, M., Davis, N., Duffy, A., Heawood, A. L. L., Power, L., Sanders, A., Singh, S. P., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202503194r · Cited by 1
BAMBI acts as a molecular switch to determine the cell fate of C2C12 myoblasts
Yao, X., & Xie, L. (2026) · Journal of Molecular Endocrinology · doi:10.1530/jme-25-0169
Metadata
- Authors
- Fan, Y., Li, X., Xiao, W., Fu, J., Harris, R. C., Lindenmeyer, M., Cohen, C. D., Guillot, N., Baron, M. H., Wang, N., Lee, K., He, J. C., Schlondorff, D., & Chuang, P. Y.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Icahn School of Medicine at Mount Sinai (US)
- Vanderbilt University School of Medicine, Nashville, TN
- University of Zurich (CH)
- Tisch Cancer Institute (US)
- Department of Medicine, Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2015-01-09
- Volume
- 64
- Issue
- 6
- Pages
- 2220-2233
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC4439561
- OpenAlex
- W2120470379
- Cited by
- 57
- References
- 59
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 3 · 2021: 6 · 2020: 7 · 2019: 9 · 2018: 7 · 2017: 9 · 2016: 2 · 2015: 2
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000320, I01BX000345)
- National Heart, Lung, and Blood Institute (R01HL062248, HL-62248)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK051265, DK52191, R01DK078897, R01DK098126, R01DK088541, R01DK052191, R01DK062794, R01DK095785)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- Bambi, TGF-beta signaling, diabetic nephropathy, diabetic glomerulopathy, VEGFR2, angiopoietin-1, ERK signaling, Smad1/5 signaling, albuminuria, glomerular permselectivity, type 2 diabetes, MEK inhibitors, TGF-beta type I receptor
- MeSH terms
- Animals, Humans, Kidney Glomerulus, Membrane Proteins, Blotting, Western, Signal Transduction, Transforming Growth Factor beta, Vascular Endothelial Growth Factor Receptor-2, Angiopoietin-1, Mice, Smad1 Protein, Smad5 Protein, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.